You are on page 1of 34

Historia

Financial Statements Base Case 2010

Exhibit 3a Five-year Forecast of Broadway's Income and Cash Flow, 2015-2019 (U


Net sales
Operating profit percentage
Interest Expense
Net income
Depreciation and amortization
Change in net working capital
Capital expenditure
Total FCF

Assumptions
Income Statement
Revenue Growth (% Change)
Gross Margin
Operating Expense (% of Revenue)
Operating Margin (% of Revenue) 1%
Common Shares 3.50
Dividend 0.84
Depreciation 1.80

Balance Sheet
Accounts recievable of Sales (% of Revenue) 9.51%
Investments and other assets increase 26.05%
Other current assets 2.03%
Accounts payable of Sales (% of Revenue) 6.75%
Accrued expenses and deferred taxes 8.42%
Other non-current liabilites 7.98%
Bank borrowing 0.40
Long Term Debt 5.95%
Corporate tax rate 35%
CAPEX (% of Revenue)
Interest Expense (% of Long Term Debt)

Income statement
Net sales 137.80
COGS 126.10
Gross profit 11.70
Operating expenses 2.90
Depreciation and amortization 1.80
Operating profit 7.00
Interest expense 0.39
Income taxes 2.31
Net income 4.30
EPS 1.23
Dividend per share 0.24
Shares outstanding 3.50
Total dividend payout 0.84

Balance sheet
Cash 1.80
Accounts receivable 13.10
Other current assets 2.80
Current assets 17.70
Net PP&E 16.00
Investments and other assets 35.90
Total assets 69.60

Accounts payable 9.30


Bank borrowing 0.40
Current Liabilities 9.70
Long Term Debt 8.20
Accrued expenses and deferred taxes 11.60
Other non-current liabilities 11.00
Total liabilities 40.50
Shareholders' equity 29.10
Total liabilities and equity 69.60

Check 0.00

Cash flow
Cash Flow from Operations
Net Income 4.30
Add: Depreciation 1.80
Less: Increase/(decrease) in accounts receivable
Less: Increase/(decrease) in Other current assets
Add: Increase/(decrease) in accounts payable
Add: Increase/(decrease) in other accrued expenses
Add: Increase/(decrease) in other non-current liabilites
Total Cash Flow from Operations

Cash Flow from Investing


Less: Increase/(decrease) in CAPEX
Less: Increase/(decrease) in investments and other assets

Total Cash Flow from Investing

Cash Flow from Financing


Add: Increase/(Decrease) in Long Term Debt
Add: Increase/(Decrease) in Borrowings
Less: Dividends Paid
Total Cash Flow from Financing

Net Cash Flow


Starting Cash
Ending Cash 1.80
Check

Supporting Schedules
PPE
PPE opening
Add: Increase/(Decrease) CapEx
Less: Depreciation 1.80
PPE closing 16.00

Net Working Capital


Add: Account recievable 13.10
Add: Other current Assets 2.80
Current Assets (less cash) 15.90
Less: Accounts payable 9.30
Less: Bank Borrowing 0.40
Net Working Capital 6.20
Change in NWC

Starting Outstanding Debt: Current Portion


Starting Outstanding Debt: Non-Current Portion
Total Starting Outstanding Debt
Principal Amortisation paid back
Interest Expense (Paid back)
Total Payments Made
Ending Oustanding Debt: Current Portion
Ending Oustanding Debt: Non-Current Portion
Total Ending Outstanding Debt
Historial Results
2011 2012 2013 2014 [E] 2015 2016

d Cash Flow, 2015-2019 (U.S. $ m


168.4 175.1
6.7 7.0
0.4 0.4
4.1 4.3
3.1 3.3
0.4 0.4
4.2 4.4
2.8 3.1

4.14% 4.18% 3.88% 4.25% -10.0% -10.0%


8.50% 8.5%
2% 2%
1% 1% 1% 1% 1.50% 2%
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84
2.20 2.50 2.80 2.90 3.10 3.30

9.41% 9.77% 9.79% 10.01% 9.69% 9.69%


26.90% 27.96% 27.82% 26.87% 27.12% 27.12%
2.79% 2.74% 2.70% 2.59% 2.57% 2.68%
6.90% 6.96% 7.08% 7.10% 6.96% 6.96%
8.92% 8.76% 8.56% 8.03% 8.54% 8.54%
7.80% 8.36% 7.34% 6.73% 7.64% 7.58%
0.40 0.40 0.40 0.40 0.40 0.40
5.37% 5.82% 5.34% 4.88% 5.47% 5.47%
35% 35% 35% 35% 35% 35%
2.10% 2.10%
4.50% 4.50%

143.50 149.50 155.30 161.90 145.71 131.14


131.50 137.10 142.50 148.60 133.32 119.99
12.00 12.40 12.80 13.30 12.39 11.15
2.90 2.90 3.00 3.00 2.91 2.62
2.20 2.50 2.80 2.90 3.10 3.30
6.90 7.00 7.00 7.40 6.37 5.22
0.36 0.41 0.39 0.37 0.36 0.34
2.29 2.31 2.31 2.46 2.11 1.71
4.25 4.28 4.30 4.57 3.91 3.18
1.21 1.22 1.23 1.30 1.12 0.91
0.24 0.24 0.24 0.24 0.24 0.24
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84

1.02 1.93 1.50 2.08 7.59 8.85


13.50 14.60 15.20 16.20 14.13 12.71
4.00 4.10 4.20 4.20 4.13 4.13
18.52 20.63 20.90 22.48 25.84 25.68
17.39 18.63 19.71 20.86 21.96 23.04
38.60 41.80 43.20 43.50 40.60 40.60
74.51 81.05 83.81 86.83 88.40 89.33

9.90 10.40 11.00 11.50 10.14 9.12


0.40 0.40 0.40 0.40 0.40 0.40
10.30 10.80 11.40 11.90 10.54 9.52
7.70 8.70 8.30 7.90 7.50 7.10
12.80 13.10 13.30 13.00 12.76 12.76
11.20 12.50 11.40 10.90 11.40 11.40
42.00 45.10 44.40 43.70 42.20 40.78
32.51 35.95 39.41 43.13 46.20 48.54
74.51 81.05 83.81 86.83 88.40 89.33

0.00 0.00 0.00 0.00 0.00 0.00

4.25 4.28 4.30 4.57 3.91 3.18


2.20 2.50 2.80 2.90 3.10 3.30
0.40 1.10 0.60 1.00 (2.07) (1.41)
1.20 0.10 0.10 - (0.08) -
0.60 0.50 0.60 0.50 (1.36) (1.01)
1.20 0.30 0.20 (0.30) (0.24) -
0.20 1.30 (1.10) (0.50) 0.50 -
6.85 7.68 6.10 6.17 8.06 6.88

3.59 3.74 3.88 4.05 4.21 4.38


2.70 3.20 1.40 0.30 (2.90) -

(6.29) (6.94) (5.28) (4.35) (1.31) (4.38)

(0.50) 1.00 (0.40) (0.40) (0.40) (0.40)


- - - - - -
0.84 0.84 0.84 0.84 0.84 0.84
(1.34) 0.16 (1.24) (1.24) (1.24) (1.24)

(0.78) 0.91 (0.43) 0.58 5.51 1.26


1.80 1.02 1.93 1.50 2.08 7.59
1.02 1.93 1.50 2.08 7.59 8.85
- - - - - -

16.00 17.39 18.63 19.71 20.86 21.96


3.59 3.74 3.88 4.05 4.21 4.38
2.20 2.50 2.80 2.90 3.10 3.30
17.39 18.63 19.71 20.86 21.96 23.04

13.50 14.60 15.20 16.20 14.13 12.71


4.00 4.10 4.20 4.20 4.13 4.13
17.50 18.70 19.40 20.40 18.25 16.84
9.90 10.40 11.00 11.50 10.14 9.12
0.40 0.40 0.40 0.40 0.40 0.40
7.20 7.90 8.00 8.50 7.71 7.31
1.00 0.70 0.10 0.50 (0.79) (0.40)

0.40 0.40
7.90 7.50
8.30 7.90
0.40 0.40
0.36 0.34
0.76 0.74
0.40 0.40
7.50 7.10
7.90 7.50
Forecasted Results
2017 2018 2019 2020 2021 2022

182.1 189.4 197.0


7.3 7.6 7.9
0.4 0.4 0.4
4.5 4.7 4.9
3.5 3.7 3.9
0.4 0.4 0.4
4.6 4.7 4.9 3.7 3.9 4.1
3.3 3.5 3.7

9.0% 9.0% 9.0% 4.5% 4.5% 4.5%


9.0% 9% 9.5% 9.5% 9.5% 9.5%
2% 2% 2% 2% 2% 2%
2.5% 3% 3% 3% 3% 3%
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84
3.50 3.70 3.90 4.10 4.30 4.50

9.69% 9.69% 9.69% 9.69% 9.69% 9.69%


27.12% 27.12% 27.12% 27.12% 27.12% 27.12%
2.66% 2.64% 2.63% 2.64% 2.65% 2.64%
6.96% 6.96% 6.96% 6.96% 6.96% 6.96%
8.54% 8.54% 8.54% 8.54% 8.54% 8.54%
7.53% 7.37% 7.37% 7.50% 7.47% 7.45%
0.40 0.40 0.40 0.40 0.40 0.40
5.47% 5.47% 5.47% 5.47% 5.47% 5.47%
35% 35% 35% 35% 35% 35%
2.10% 2.10% 2.10% 2.10% 2.10% 2.10%
4.50% 4.50% 4.50% 4.50% 4.50% 4.50%

142.94 155.81 169.83 177.47 185.46 193.80


130.08 141.78 153.70 160.61 167.84 175.39
12.86 14.02 16.13 16.86 17.62 18.41
2.86 3.12 3.40 3.55 3.71 3.88
3.50 3.70 3.90 4.10 4.30 4.50
6.51 7.21 8.84 9.21 9.61 10.04
0.32 0.30 0.28 0.27 0.25 0.23
2.17 2.42 2.99 3.13 3.28 3.43
4.02 4.49 5.56 5.81 6.09 6.37
1.15 1.28 1.59 1.66 1.74 1.82
0.24 0.24 0.24 0.24 0.24 0.24
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84

10.25 12.11 15.02 19.76 24.79 30.13


13.86 15.11 16.46 17.21 17.98 18.79
4.13 4.13 4.13 4.13 4.13 4.13
28.23 31.34 35.61 41.09 46.90 53.04
24.10 25.13 26.15 25.78 25.38 24.95
40.60 40.60 40.60 40.60 40.60 40.60
92.93 97.07 102.37 107.47 112.87 118.59

9.95 10.84 11.82 12.35 12.90 13.49


0.40 0.40 0.40 0.40 0.40 0.40
10.35 11.24 12.22 12.75 13.30 13.89
6.70 6.30 5.90 5.50 5.10 4.70
12.76 12.76 12.76 12.76 12.76 12.76
11.40 11.40 11.40 11.40 11.40 11.40
41.21 41.70 42.28 42.41 42.56 42.75
51.72 55.37 60.09 65.06 70.31 75.84
92.93 97.07 102.37 107.47 112.87 118.59

0.00 0.00 0.00 0.00 0.00 0.00

4.02 4.49 5.56 5.81 6.09 6.37


3.50 3.70 3.90 4.10 4.30 4.50
1.14 1.25 1.36 0.74 0.77 0.81
- - - - - -
0.82 0.90 0.98 0.53 0.56 0.58
- - - - - -
- - - - - -
7.20 7.84 9.08 9.70 10.17 10.65

4.55 4.74 4.92 3.73 3.89 4.07


- - - - - -

(4.55) (4.74) (4.92) (3.73) (3.89) (4.07)

(0.40) (0.40) (0.40) (0.40) (0.40) (0.40)


- - - - - -
0.84 0.84 0.84 0.84 0.84 0.84
(1.24) (1.24) (1.24) (1.24) (1.24) (1.24)

1.41 1.86 2.91 4.74 5.03 5.34


8.85 10.25 12.11 15.02 19.76 24.79
10.25 12.11 15.02 19.76 24.79 30.13
- - - - - -

23.04 24.10 25.13 26.15 25.78 25.38


4.55 4.74 4.92 3.73 3.89 4.07
3.50 3.70 3.90 4.10 4.30 4.50
24.10 25.13 26.15 25.78 25.38 24.95

13.86 15.11 16.46 17.21 17.98 18.79


4.13 4.13 4.13 4.13 4.13 4.13
17.98 19.23 20.59 21.33 22.10 22.91
9.95 10.84 11.82 12.35 12.90 13.49
0.40 0.40 0.40 0.40 0.40 0.40
7.64 7.99 8.37 8.58 8.80 9.03
0.32 0.35 0.38 0.21 0.22 0.23

0.40 0.40 0.40 0.40 0.40 0.40


7.10 6.70 6.30 5.90 5.50 5.10
7.50 7.10 6.70 6.30 5.90 5.50
0.40 0.40 0.40 0.40 0.40 0.40
0.32 0.30 0.28 0.27 0.25 0.23
0.72 0.70 0.68 0.67 0.65 0.63
0.40 0.40 0.40 0.40 0.40 0.40
6.70 6.30 5.90 5.50 5.10 4.70
7.10 6.70 6.30 5.90 5.50 5.10
2023 2024 Exp

4.3 4.4

4.5% 4.5% Broadway's revenue to decline at 10% per year from 2015 to 2016, then grow
9.5% 9.5% Broadway's gross margin to grow at 8.5% per year from 2015 to 2016, then 9%
2% 2% Operating expense is expected to remain constant at 2% of annual sale
3% 3%
3.50 3.50
0.84 0.84
4.70 4.90 Depreciation would increase by $200,000 per year in the foreseeable future

9.69% 9.69% Assume constant AVG value from Exhibit 2 2014 financial statement so have t
27.12% 27.12% Assume constant AVG value from Exhibit 2 2014 financial statement so have t
2.64% 2.64%
6.96% 6.96% Assume constant AVG value from Exhibit 2 2014 financial statement so have t
8.54% 8.54% Assume constant AVG value from Exhibit 2 2014 financial statement so have t
7.43% 7.44% Assume constant value from Exhibit 2 2014 financial statement so have take t
0.40 0.40 Amount given in Exhibit 2 2014 Financial Statement
5.47% 5.47% Assume constant AVG value from Exhibit 2 2014 financial statement so have t
35% 35% The standard industry tax rate value given
2.10% 2.10% Capital Expenditure is expected to remain constant at 2.10% of annual sales
4.50% 4.50% Rate given in Exhibit 2 2014 Financial Statement

202.52 211.64
183.28 191.53
19.24 20.11
4.05 4.23
4.70 4.90
10.49 10.97
0.21 0.19
3.60 3.77
6.68 7.01
1.91 2.00
0.24 0.24
3.50 3.50
0.84 0.84

35.78 41.75
19.63 20.52
4.13 4.13
59.54 66.39
24.50 24.04
40.60 40.60
124.64 131.04

14.09 14.73
0.40 0.40
14.49 15.13
4.30 3.90
12.76 12.76
11.40 11.40
42.95 43.19
81.68 87.85
124.64 131.04

0.00 0.00

6.68 7.01
4.70 4.90
0.85 0.88
- -
0.61 0.63
- -
- -
11.14 11.66

4.25 4.44
- -

(4.25) (4.44)

(0.40) (0.40)
- -
0.84 0.84
(1.24) (1.24)

5.65 5.97
30.13 35.78
35.78 41.75
- -

24.95 24.50
4.25 4.44
4.70 4.90
24.50 24.04

19.63 20.52
4.13 4.13
23.76 24.64
14.09 14.73
0.40 0.40
9.27 9.52
0.24 0.25

0.40 0.40
4.70 4.30
5.10 4.70
0.40 0.40
0.21 0.19
0.61 0.59
0.40 0.40
4.30 3.90
4.70 4.30
Explanation

ear from 2015 to 2016, then grow at 9% per year from 2017 to 2019 and 4.5% per year thereafter
er year from 2015 to 2016, then 9% per year from 2017 to 2018 and 9.5% per year thereafter
onstant at 2% of annual sale

er year in the foreseeable future

2014 financial statement so have take the average of 2010-2014, since no new information given for 2014 onwards
2014 financial statement so have take the average of 2010-2014, since no new information given for 2014 onwards

2014 financial statement so have take the average of 2010-2014, since no new information given for 2014 onwards
2014 financial statement so have take the average of 2010-2014, since no new information given for 2014 onwards
financial statement so have take the average of 2010-2014, since no new information given for 2014 onwards

2014 financial statement so have take the average of 2010-2014, since no new information given for 2014 onwards

onstant at 2.10% of annual sales


2017 to 2019 and 4.5% per year thereafter
7 to 2018 and 9.5% per year thereafter

010-2014, since no new information given for 2014 onwards


010-2014, since no new information given for 2014 onwards

010-2014, since no new information given for 2014 onwards


010-2014, since no new information given for 2014 onwards
2014, since no new information given for 2014 onwards

010-2014, since no new information given for 2014 onwards


His
Financial Statements Pessimistic Case 2010

Exhibit 3a Five-year Forecast of Broadway's Income and Cash Flow, 2015-2019 (U.S. $
Net sales
Operating profit percentage
Interest Expense
Net income
Depreciation and amortization
Change in net working capital
Capital expenditure
Total FCF

Assumptions
Income Statement
Revenue Growth (% Change)
Gross Margin
Operating Expense (% of Revenue)
Operating Margin (% of Revenue) 1%
Common Shares 3.50
Dividend 0.84
Depreciation 1.80

Balance Sheet
Accounts recievable of Sales (% of Revenue) 9.51%
Investments and other assets increase 26.05%
Other current assets 2.03%
Accounts payable of Sales (% of Revenue) 6.75%
Accrued expenses and deferred taxes 8.42%
Other non-current liabilites 7.98%
Bank borrowing 0.40
Long Term Debt 5.95%
Corporate tax rate 35%
CAPEX (% of Revenue)
Interest Expense (% of Long Term Debt)

Income statement
Net sales 137.80
COGS 126.10
Gross profit 11.70
Operating expenses 2.90
Depreciation and amortization 1.80
Operating profit 7.00
Interest expense 0.39
Income taxes 2.31
Net income 4.30
EPS 1.23
Dividend per share 0.24
Shares outstanding 3.50
Total dividend payout 0.84

Balance sheet
Cash 1.80
Accounts receivable 13.10
Other current assets 2.80
Current assets 17.70
Net PP&E 16.00
Investments and other assets 35.90
Total assets 69.60

Accounts payable 9.30


Bank borrowing 0.40
Current Liabilities 9.70
Long Term Debt 8.20
Accrued expenses and deferred taxes 11.60
Other non-current liabilities 11.00
Total liabilities 40.50
Shareholders' equity 29.10
Total liabilities and equity 69.60

Check 0.00

Cash flow
Cash Flow from Operations
Net Income 4.30
Add: Depreciation 1.80
Less: Increase/(decrease) in accounts receivable
Less: Increase/(decrease) in Other current assets
Add: Increase/(decrease) in accounts payable
Add: Increase/(decrease) in other accrued expenses
Add: Increase/(decrease) in other non-current liabilites
Total Cash Flow from Operations

Cash Flow from Investing


Less: Increase/(decrease) in CAPEX
Less: Increase/(decrease) in investments and other assets

Total Cash Flow from Investing

Cash Flow from Financing


Add: Increase/(Decrease) in Long Term Debt
Add: Increase/(Decrease) in Borrowings
Less: Dividends Paid
Total Cash Flow from Financing

Net Cash Flow


Starting Cash
Ending Cash 1.80
Check

Supporting Schedules
PPE
PPE opening
Add: Increase/(Decrease) CapEx
Less: Depreciation 1.80
PPE closing 16.00

Net Working Capital


Add: Account recievable 13.10
Add: Other current Assets 2.80
Current Assets (less cash) 15.90
Less: Accounts payable 9.30
Less: Bank Borrowing 0.40
Net Working Capital 6.20
Change in NWC

Starting Outstanding Debt: Current Portion


Starting Outstanding Debt: Non-Current Portion
Total Starting Outstanding Debt
Principal Amortisation paid back
Interest Expense (Paid back)
Total Payments Made
Ending Oustanding Debt: Current Portion
Ending Oustanding Debt: Non-Current Portion
Total Ending Outstanding Debt
Historial Results
2011 2012 2013 2014 [E] 2015 2016

w, 2015-2019 (U.S. $ millions)*


168.4 175.1
6.7 7.0
0.4 0.4
4.1 4.3
3.1 3.3
0.4 0.4
4.2 4.4
2.8 3.1

4.14% 4.18% 3.88% 4.25% -15.0% -15.0%


8.50% 8.5%
2.4% 2.4%
1% 1% 1% 1% 1.50% 2%
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84
2.20 2.50 2.80 2.90 3.10 3.30

9.41% 9.77% 9.79% 10.01% 9.69% 9.69%


26.90% 27.96% 27.82% 26.87% 27.12% 27.12%
2.79% 2.74% 2.70% 2.59% 2.57% 2.68%
6.90% 6.96% 7.08% 7.10% 6.96% 6.96%
8.92% 8.76% 8.56% 8.03% 8.54% 8.54%
7.80% 8.36% 7.34% 6.73% 7.64% 7.58%
0.40 0.40 0.40 0.40 0.40 0.40
5.37% 5.82% 5.34% 4.88% 5.47% 5.47%
35% 35% 35% 35% 35% 35%
2.10% 2.10%
4.50% 4.50%

143.50 149.50 155.30 161.90 137.62 116.97


131.50 137.10 142.50 148.60 125.92 107.03
12.00 12.40 12.80 13.30 11.70 9.94
2.90 2.90 3.00 3.00 3.30 2.81
2.20 2.50 2.80 2.90 3.10 3.30
6.90 7.00 7.00 7.40 5.29 3.84
0.36 0.41 0.39 0.37 0.36 0.34
2.29 2.31 2.31 2.46 1.73 1.22
4.25 4.28 4.30 4.57 3.21 2.27
1.21 1.22 1.23 1.30 0.92 0.65
0.24 0.24 0.24 0.24 0.24 0.24
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84

1.02 1.93 1.50 2.08 7.37 7.90


13.50 14.60 15.20 16.20 13.34 11.34
4.00 4.10 4.20 4.20 3.86 3.86
18.52 20.63 20.90 22.48 24.58 23.10
17.39 18.63 19.71 20.86 21.96 23.04
38.60 41.80 43.20 43.50 40.60 40.60
74.51 81.05 83.81 86.83 87.14 86.74

9.90 10.40 11.00 11.50 9.58 8.14


0.40 0.40 0.40 0.40 0.40 0.40
10.30 10.80 11.40 11.90 9.98 8.54
7.70 8.70 8.30 7.90 7.50 7.10
12.80 13.10 13.30 13.00 12.76 12.76
11.20 12.50 11.40 10.90 11.40 11.40
42.00 45.10 44.40 43.70 41.64 39.80
32.51 35.95 39.41 43.13 45.51 46.94
74.51 81.05 83.81 86.83 87.14 86.74

0.00 0.00 0.00 0.00 0.00 0.00

4.25 4.28 4.30 4.57 3.21 2.27


2.20 2.50 2.80 2.90 3.10 3.30
0.40 1.10 0.60 1.00 (2.86) (2.00)
1.20 0.10 0.10 - (0.34) -
0.60 0.50 0.60 0.50 (1.92) (1.44)
1.20 0.30 0.20 (0.30) (0.24) -
0.20 1.30 (1.10) (0.50) 0.50 -
6.85 7.68 6.10 6.17 7.84 6.14

3.59 3.74 3.88 4.05 4.21 4.38


2.70 3.20 1.40 0.30 (2.90) -

(6.29) (6.94) (5.28) (4.35) (1.31) (4.38)

(0.50) 1.00 (0.40) (0.40) (0.40) (0.40)


- - - - - -
0.84 0.84 0.84 0.84 0.84 0.84
(1.34) 0.16 (1.24) (1.24) (1.24) (1.24)

(0.78) 0.91 (0.43) 0.58 5.29 0.52


1.80 1.02 1.93 1.50 2.08 7.37
1.02 1.93 1.50 2.08 7.37 7.90
- - - - - -

16.00 17.39 18.63 19.71 20.86 21.96


3.59 3.74 3.88 4.05 4.21 4.38
2.20 2.50 2.80 2.90 3.10 3.30
17.39 18.63 19.71 20.86 21.96 23.04

13.50 14.60 15.20 16.20 13.34 11.34


4.00 4.10 4.20 4.20 3.86 3.86
17.50 18.70 19.40 20.40 17.20 15.20
9.90 10.40 11.00 11.50 9.58 8.14
0.40 0.40 0.40 0.40 0.40 0.40
7.20 7.90 8.00 8.50 7.23 6.66
1.00 0.70 0.10 0.50 (1.27) (0.56)

0.40 0.40
7.90 7.50
8.30 7.90
0.40 0.40
0.36 0.34
0.76 0.74
0.40 0.40
7.50 7.10
7.90 7.50
Forecasted Results
2017 2018 2019 2020 2021 2022

182.1 189.4 197.0


7.3 7.6 7.9
0.4 0.4 0.4
4.5 4.7 4.9
3.5 3.7 3.9
0.4 0.4 0.4
4.6 4.7 4.9 3.2 3.3 3.4
3.3 3.5 3.7

8.0% 8.0% 8.0% 3.5% 3.5% 3.5%


8.5% 9% 9.0% 9.0% 9.0% 9.0%
2.4% 2.4% 2.4% 2.4% 2.4% 2.4%
2.5% 3% 3% 3% 3% 3%
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84
3.50 3.70 3.90 4.10 4.30 4.50

9.69% 9.69% 9.69% 9.69% 9.69% 9.69%


27.12% 27.12% 27.12% 27.12% 27.12% 27.12%
2.66% 2.64% 2.63% 2.64% 2.65% 2.64%
6.96% 6.96% 6.96% 6.96% 6.96% 6.96%
8.54% 8.54% 8.54% 8.54% 8.54% 8.54%
7.53% 7.37% 7.37% 7.50% 7.47% 7.45%
0.40 0.40 0.40 0.40 0.40 0.40
5.47% 5.47% 5.47% 5.47% 5.47% 5.47%
35% 35% 35% 35% 35% 35%
2.10% 2.10% 2.10% 2.10% 2.10% 2.10%
4.50% 4.50% 4.50% 4.50% 4.50% 4.50%

126.33 136.44 147.35 152.51 157.85 163.37


115.59 124.16 134.09 138.78 143.64 148.67
10.74 12.28 13.26 13.73 14.21 14.70
3.03 3.27 3.54 3.66 3.79 3.92
3.50 3.70 3.90 4.10 4.30 4.50
4.21 5.30 5.83 5.97 6.12 6.28
0.32 0.30 0.28 0.27 0.25 0.23
1.36 1.75 1.94 2.00 2.05 2.12
2.53 3.25 3.60 3.71 3.82 3.93
0.72 0.93 1.03 1.06 1.09 1.12
0.24 0.24 0.24 0.24 0.24 0.24
3.50 3.50 3.50 3.50 3.50 3.50
0.84 0.84 0.84 0.84 0.84 0.84

7.87 8.57 9.61 12.83 16.25 19.86


12.25 13.23 14.29 14.79 15.30 15.84
3.86 3.86 3.86 3.86 3.86 3.86
23.98 25.66 27.76 31.48 35.41 39.56
24.10 25.13 26.15 25.26 24.27 23.20
40.60 40.60 40.60 40.60 40.60 40.60
88.68 91.39 94.51 97.34 100.28 103.36

8.79 9.49 10.25 10.61 10.98 11.37


0.40 0.40 0.40 0.40 0.40 0.40
9.19 9.89 10.65 11.01 11.38 11.77
6.70 6.30 5.90 5.50 5.10 4.70
12.76 12.76 12.76 12.76 12.76 12.76
11.40 11.40 11.40 11.40 11.40 11.40
40.05 40.35 40.71 40.67 40.64 40.63
48.62 51.04 53.80 56.66 59.64 62.73
88.68 91.39 94.51 97.34 100.28 103.36

0.00 0.00 0.00 0.00 0.00 0.00

2.53 3.25 3.60 3.71 3.82 3.93


3.50 3.70 3.90 4.10 4.30 4.50
0.91 0.98 1.06 0.50 0.52 0.54
- - - - - -
0.65 0.70 0.76 0.36 0.37 0.38
- - - - - -
- - - - - -
5.77 6.68 7.20 7.66 7.97 8.28

4.55 4.74 4.92 3.20 3.31 3.43


- - - - - -

(4.55) (4.74) (4.92) (3.20) (3.31) (3.43)

(0.40) (0.40) (0.40) (0.40) (0.40) (0.40)


- - - - - -
0.84 0.84 0.84 0.84 0.84 0.84
(1.24) (1.24) (1.24) (1.24) (1.24) (1.24)

(0.02) 0.70 1.04 3.22 3.41 3.61


7.90 7.87 8.57 9.61 12.83 16.25
7.87 8.57 9.61 12.83 16.25 19.86
- - - - - -

23.04 24.10 25.13 26.15 25.26 24.27


4.55 4.74 4.92 3.20 3.31 3.43
3.50 3.70 3.90 4.10 4.30 4.50
24.10 25.13 26.15 25.26 24.27 23.20

12.25 13.23 14.29 14.79 15.30 15.84


3.86 3.86 3.86 3.86 3.86 3.86
16.11 17.09 18.15 18.65 19.16 19.70
8.79 9.49 10.25 10.61 10.98 11.37
0.40 0.40 0.40 0.40 0.40 0.40
6.92 7.19 7.49 7.63 7.78 7.93
0.26 0.28 0.30 0.14 0.15 0.15

0.40 0.40 0.40 0.40 0.40 0.40


7.10 6.70 6.30 5.90 5.50 5.10
7.50 7.10 6.70 6.30 5.90 5.50
0.40 0.40 0.40 0.40 0.40 0.40
0.32 0.30 0.28 0.27 0.25 0.23
0.72 0.70 0.68 0.67 0.65 0.63
0.40 0.40 0.40 0.40 0.40 0.40
6.70 6.30 5.90 5.50 5.10 4.70
7.10 6.70 6.30 5.90 5.50 5.10
2023 2024

3.6 3.7

3.5% 3.5%
9.0% 9.0%
2.4% 2.4%
3% 3%
3.50 3.50
0.84 0.84
4.70 4.90

9.69% 9.69%
27.12% 27.12%
2.64% 2.64%
6.96% 6.96%
8.54% 8.54%
7.43% 7.44%
0.40 0.40
5.47% 5.47%
35% 35%
2.10% 2.10%
4.50% 4.50%

169.09 175.01
153.87 159.26
15.22 15.75
4.06 4.20
4.70 4.90
6.46 6.65
0.21 0.19
2.19 2.26
4.06 4.20
1.16 1.20
0.24 0.24
3.50 3.50
0.84 0.84

23.68 27.69
16.39 16.97
3.86 3.86
43.93 48.52
22.05 20.83
40.60 40.60
106.58 109.95

11.77 12.18
0.40 0.40
12.17 12.58
4.30 3.90
12.76 12.76
11.40 11.40
40.63 40.64
65.96 69.31
106.58 109.95

0.00 0.00

4.06 4.20
4.70 4.90
0.55 0.57
- -
0.40 0.41
- -
- -
8.60 8.94

3.55 3.68
- -

(3.55) (3.68)

(0.40) (0.40)
- -
0.84 0.84
(1.24) (1.24)

3.81 4.02
19.86 23.68
23.68 27.69
- -

23.20 22.05
3.55 3.68
4.70 4.90
22.05 20.83

16.39 16.97
3.86 3.86
20.25 20.83
11.77 12.18
0.40 0.40
8.09 8.25
0.16 0.16

0.40 0.40
4.70 4.30
5.10 4.70
0.40 0.40
0.21 0.19
0.61 0.59
0.40 0.40
4.30 3.90
4.70 4.30

You might also like